We are Sorry, This Page doesn't Exist

An unprecedented biotech investment boom means smaller companies can accelerate early-stage drug trials and, potentially, carry them to more patients faster......»»

Eating fiber-filled whole grains can help reduce the risk of colon cancer. A cancer di.....»»

Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says......»»

AstraZeneca's updated data from TOPAZ-1 Phase 3 trial of Imfinzi (durvalumab) in advanced biliary tract cancer patients. Unveiling long-term survival benefits and significant overall survival improvement. read more.....»»

The plan is to grow revenue from treating the sickest, most complex patients......»»

The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street......»»

“The pricing is coming down, but it’s still cash and it’s still a tremendous expense for our patients,” Collins said......»»

The fact that a smaller percentage of cases involve elderly adults is a sign that the vaccine is working......»»

Optical component and module maker Young Optics has become a supplier of DLP .....»»

Dematic, which moved its HQ to Midtown in 2019, had plans to grow into its space over a 6-year period. Now, 18 months later, they're running out of room......»»

read more.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Shares of Pfizer Inc. gained 0.2% in premarket trading on Thursday af.....»»

Harvest Hosts members can stay overnight in their RVs at over 2,000 locations ac.....»»

The global laryngeal cancer therapeutics market is expected to grow by $635.07 million during 2021-2025 helped by Amgen Inc (NASDAQ: AMGN) and AstraZeneca Plc (NYSE: AZN) as key contributors to growth, acco.....»»

Immatics NV (NASDAQ: IMTX) has announced a clinical data update from the dose-escalation cohorts of the ongoing Phase 1 trial evaluating its ACTengine product candidates IMA201, IMA202, and IMA read more.....»»

"Imagine filling a bucket of water that has a hole in the bottom," he said. "That's where we've been. We've been trying to fill the bucket, and the water keeps coming out.".....»»

When Dr. David Waterhouse first arrived in Cincinnati in 1994 as a medical oncologist and hematologist at OHC, not a lot of cancer research was happening in the community. That has drastically changed over the last 27 years......»»

STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- "Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic cancer. The results show a promising safety profile w.....»»

A newborn in Washington, DC with severe COVID-19 was found to have a new variant of the virus and massive viral load. Researchers are puzzled. Nurses care for a newborn at Diaconesses Hospital in Paris on.....»»